4//SEC Filing
Patel Anish 4
Accession 0001967163-26-000001
CIK 0001672619other
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 5:54 PM ET
Size
7.2 KB
Accession
0001967163-26-000001
Insider Transaction Report
Form 4
Patel Anish
CHIEF OPERATING OFFICER
Transactions
- Sale
Common Stock
[F1][F2][F3]2026-01-09$27.98/sh−48,057$1,344,837→ 215,254 total(indirect: See footnote) - Sale
Common Stock
[F1][F3]2026-01-09$28.50/sh−243$6,926→ 215,011 total(indirect: See footnote)
Footnotes (3)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on September 30, 2024 by the Reporting Person and by The Patel / Dong Family Trust Dated August 24, 2017, for which the Reporting Person serves as trustee (the "Patel / Dong Family Trust").
- [F2]This transaction was executed in multiple trades at prices ranging from $27.50 to $28.38. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- [F3]The shares are held by The Patel / Dong Family Trust.
Signature
/s/ Ben Hohl, by power of attorney|2026-01-13
Documents
Issuer
Enliven Therapeutics, Inc.
CIK 0001672619
Entity typeother
Related Parties
1- filerCIK 0001967163
Filing Metadata
- Form type
- 4
- Filed
- Jan 12, 7:00 PM ET
- Accepted
- Jan 13, 5:54 PM ET
- Size
- 7.2 KB